Clinical trial
Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing…
NCT00434044 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00434044 |
|---|---|
| Title | Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis |
| Official title | Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase III Study of Etanercept in the Treatment of Subjects With Ankylosing Spondylitis |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | Enbrel (etanercept) |
| Enrollment | 150 |
| Start date | Feb 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Feb 12, 2007 |
| Last update posted | Dec 13, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: